221 related articles for article (PubMed ID: 23097625)
1. Role of transcriptional corepressor CtBP1 in prostate cancer progression.
Wang R; Asangani IA; Chakravarthi BV; Ateeq B; Lonigro RJ; Cao Q; Mani RS; Camacho DF; McGregor N; Schumann TE; Jing X; Menawat R; Tomlins SA; Zheng H; Otte AP; Mehra R; Siddiqui J; Dhanasekaran SM; Nyati MK; Pienta KJ; Palanisamy N; Kunju LP; Rubin MA; Chinnaiyan AM; Varambally S
Neoplasia; 2012 Oct; 14(10):905-14. PubMed ID: 23097625
[TBL] [Abstract][Full Text] [Related]
2. Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice.
Moiola CP; De Luca P; Zalazar F; Cotignola J; Rodríguez-Seguí SA; Gardner K; Meiss R; Vallecorsa P; Pignataro O; Mazza O; Vazquez ES; De Siervi A
Clin Cancer Res; 2014 Aug; 20(15):4086-95. PubMed ID: 24842953
[TBL] [Abstract][Full Text] [Related]
3. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
Chakravarthi BVSK; Chandrashekar DS; Agarwal S; Balasubramanya SAH; Pathi SS; Goswami MT; Jing X; Wang R; Mehra R; Asangani IA; Chinnaiyan AM; Manne U; Sonpavde G; Netto GJ; Gordetsky J; Varambally S
Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958
[TBL] [Abstract][Full Text] [Related]
4. CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice.
Dalton GN; Massillo C; Scalise GD; Duca R; Porretti J; Farré PL; Gardner K; Paez A; Gueron G; De Luca P; De Siervi A
Cell Death Dis; 2019 Apr; 10(4):299. PubMed ID: 30931931
[TBL] [Abstract][Full Text] [Related]
5. Fanconi anemia proteins interact with CtBP1 and modulate the expression of the Wnt antagonist Dickkopf-1.
Huard CC; Tremblay CS; Helsper K; Delisle MC; Schindler D; Lévesque G; Carreau M
Blood; 2013 Mar; 121(10):1729-39. PubMed ID: 23303816
[TBL] [Abstract][Full Text] [Related]
6. LncRNA CTBP1-AS inhibits TP63-mediated activation of S100A14 during prostate cancer progression.
Wu G; Dong Z; Dong Y; Chen Y; Zhu H; Ding D; Cui Y; Wang Y; Xu Y; Chen H
Cancer Sci; 2024 May; 115(5):1492-1504. PubMed ID: 38476086
[TBL] [Abstract][Full Text] [Related]
7. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
Deng Y; Guo W; Xu N; Li F; Li J
Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
[TBL] [Abstract][Full Text] [Related]
8. Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer.
Takayama K; Horie-Inoue K; Katayama S; Suzuki T; Tsutsumi S; Ikeda K; Urano T; Fujimura T; Takagi K; Takahashi S; Homma Y; Ouchi Y; Aburatani H; Hayashizaki Y; Inoue S
EMBO J; 2013 Jun; 32(12):1665-80. PubMed ID: 23644382
[TBL] [Abstract][Full Text] [Related]
9. CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndrome.
Massillo C; Dalton GN; Porretti J; Scalise GD; Farré PL; Piccioni F; Secchiari F; Pascuali N; Clyne C; Gardner K; De Luca P; De Siervi A
Int J Cancer; 2019 Mar; 144(5):1115-1127. PubMed ID: 30152543
[TBL] [Abstract][Full Text] [Related]
10. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
Blevins MA; Huang M; Zhao R
Mol Cancer Ther; 2017 Jun; 16(6):981-990. PubMed ID: 28576945
[TBL] [Abstract][Full Text] [Related]
11. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
[TBL] [Abstract][Full Text] [Related]
12. Succinylation of CTBP1 mediated by KAT2A suppresses its inhibitory activity on the transcription of CDH1 to promote the progression of prostate cancer.
Zhou J; Yan X; Liu Y; Yang J
Biochem Biophys Res Commun; 2023 Apr; 650():9-16. PubMed ID: 36764210
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
[TBL] [Abstract][Full Text] [Related]
14. The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.
Chakravarthi BV; Pathi SS; Goswami MT; Cieślik M; Zheng H; Nallasivam S; Arekapudi SR; Jing X; Siddiqui J; Athanikar J; Carskadon SL; Lonigro RJ; Kunju LP; Chinnaiyan AM; Palanisamy N; Varambally S
Oncotarget; 2014 Aug; 5(16):6654-69. PubMed ID: 25115393
[TBL] [Abstract][Full Text] [Related]
15. CtBP1 interacts with SOX2 to promote the growth, migration and invasion of lung adenocarcinoma.
Liu Y; Bian T; Feng J; Qian L; Li X; Zhang Q; Zhang J; Jiang D; Liu J; Shi J
Oncol Rep; 2019 Jul; 42(1):67-78. PubMed ID: 31059077
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
Li M; Riddle S; Zhang H; D'Alessandro A; Flockton A; Serkova NJ; Hansen KC; Moldovan R; McKeon BA; Frid M; Kumar S; Li H; Liu H; Caánovas A; Medrano JF; Thomas MG; Iloska D; Plecitá-Hlavatá L; Ježek P; Pullamsetti S; Fini MA; El Kasmi KC; Zhang Q; Stenmark KR
Circulation; 2016 Oct; 134(15):1105-1121. PubMed ID: 27562971
[TBL] [Abstract][Full Text] [Related]
17. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
[TBL] [Abstract][Full Text] [Related]
18. The CtBP1-p300-FOXO3a transcriptional complex represses the expression of the apoptotic regulators Bax and Bim in human osteosarcoma cells.
Li C; Xiao XQ; Qian YH; Zhou ZY
J Cell Physiol; 2019 Dec; 234(12):22365-22377. PubMed ID: 31074088
[TBL] [Abstract][Full Text] [Related]
19. The low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer.
Bizama C; Benavente F; Salvatierra E; Gutiérrez-Moraga A; Espinoza JA; Fernández EA; Roa I; Mazzolini G; Sagredo EA; Gidekel M; Podhajcer OL
Int J Cancer; 2014 Feb; 134(4):755-64. PubMed ID: 23907728
[TBL] [Abstract][Full Text] [Related]
20. CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease.
Porretti J; Dalton GN; Massillo C; Scalise GD; Farré PL; Elble R; Gerez EN; Accialini P; Cabanillas AM; Gardner K; De Luca P; De Siervi A
Int J Cancer; 2018 Aug; 143(4):897-906. PubMed ID: 29536528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]